Blockchain intelligence firm TRM Labs has reported a significant increase in cryptocurrency payments to Chinese precursor manufacturers, indicating a growing preference for digital assets within this industry. In 2023 alone, over $26 million in crypto was deposited into wallets associated with these entities, with approximately 60% of payments made in Bitcoin.
TRM Labs, which boasts backing from major financial institutions like JPMorgan Chase, Visa, Citi, and PayPal, observed a sixfold surge in crypto deposits from 2022 to 2023. Their recent research report disclosed that deposits into addresses linked to Chinese drug producers more than doubled in the first four months of 2024 compared to the same period in 2023. Notably, 11 manufacturers accounted for over 70% of all crypto-denominated sales of drug precursors.
The sources of crypto funds to Chinese precursor manufacturers vary, with most transactions originating from unhosted wallets, cryptocurrency exchanges, and payment services. These manufacturers commonly host their wallets on exchanges. Analysis of payment volume reveals that approximately 60% of crypto payments to Chinese precursor manufacturers occurred on the Bitcoin blockchain, followed by 30% on TRON and about 6% on Ethereum.
Despite the increasing trend in crypto payments, Chinese manufacturers also exhibit a willingness to accept fiat currencies through platforms like PayPal, MoneyGram, Western Union, and bank transfers.
According to TRM Labs’ findings, Chinese drug precursor exports primarily target countries including Canada, the Netherlands, Australia, Germany, and the U.S. However, there are also indications of advertisements targeting Russia and neighboring nations for mephedrone precursors.
The issue of illicit fentanyl precursors has drawn attention globally, with a U.S. congressional committee reporting China’s subsidization of their production, contributing to the opioid crisis in the United States. This support includes value-added tax rebates for companies manufacturing fentanyl analogs, precursors, and synthetic narcotics, provided they sell these products outside China.
Another blockchain intelligence firm, Elliptic, has highlighted the attractiveness of fentanyl to drug cartels due to its lower production cost compared to heroin and its significantly higher potency, making it the leading cause of death for Americans aged 18-45.